{"count":10,"index":{"built_at":"2026-07-28T02:53:01.407298+00:00","public_records":55311,"revision":"1df28ac1767dc329f781d4e1"},"query":{"area":null,"kind":null,"lang":null,"limit":10,"match_mode":"all_terms","q":"Evidence check: HDL in the context of menopause"},"results":[{"answer":"HDL cholesterol levels often shift during menopause: estrogen decline can lower HDL or alter subclass distribution (less large, protective HDL2). However, the HDL-raising hypothesis has been largely refuted by CETP inhibitor trials and Mendelian randomization – HDL is a risk marker, not a causal protective factor. More relevant are HDL functionality (cholesterol efflux capacity) and the full lipid panel (LDL, triglycerides, Lp(a)). The 2025 ESC/EAS guidelines emphasize LDL reduction and universal Lp(a) screening, not HDL elevation. For menopausal women, this means: HDL in the normal range is fine, but isolated HDL boosting via lifestyle (e.g., alcohol, estrogen) is not cardioprotective. Focus should be on overall lipid profile, blood pressure, glucose, and lifestyle (exercise, Mediterranean diet). Evidence: human-moderate (observational studies, no RCTs for HDL raising).","area":"gesundheit","canonical_id":"gesundheit:canonical-825e46b6ec9d3001fc982346","id":"public-50dbe77e94fd9cc230f16d6b","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: HDL in the context of menopause","score":21.91269184,"snippet":"HDL cholesterol levels often shift during menopause: estrogen decline can lower HDL or alter subclass distribution (less large, protective HDL2). However, the HDL-raising hypothesis has been largely refuted by CETP inhibitor trials and Mendelian randomization – HDL is a risk marker, not a causal protective factor. More relevant are HDL functionality (cholesterol efflux capacity) and the full lipid panel (LDL, triglycerides, Lp(a)). The 2025 ESC/EAS guidelines emphasize LDL reduction and universal Lp(a) screening, not HDL elevation. For menopausal women, this means: HDL in the normal range is fine, but isolated HDL boosting via lifestyle (e.g., alcohol, estrogen) is not cardioprotective. Focu","sources":[],"title":"Evidence check: HDL in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-50dbe77e94fd9cc230f16d6b/evidence-check-hdl-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Menopause (Wechseljahre) involves hormonal shifts that can alter lipid profiles. HDL cholesterol ('good' cholesterol) shows a nuanced pattern: during perimenopause HDL may initially rise, but later it can decline or shift toward less protective subtypes (smaller HDL particles). Evidence is based on observational studies and is rated 'human-moderate' – no large RCTs prove a causal menopause effect on HDL. Caveat: isolated low HDL is not a standalone risk factor; it must be interpreted alongside LDL, triglycerides, and overall cardiovascular risk. Lifestyle interventions (exercise, Mediterranean diet, smoking cessation) remain the most evidence-supported ways to support HDL. Hormone therapy may raise HDL but its clinical benefit is debated. The provided context lacks direct data on HDL and menopause; this answer relies on general medical knowledge. Consumers should not over-focus on a single biomarker – a comprehensive health check including blood pressure, glucose, and inflammation markers is more informative.","area":"gesundheit","canonical_id":"gesundheit:canonical-8a1d96215378bf1d195e0af8","id":"public-3fd14b1cbabd6d5fe86f0d7b","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: HDL in the context of Wechseljahre","score":21.59368418,"snippet":"Menopause (Wechseljahre) involves hormonal shifts that can alter lipid profiles. HDL cholesterol ('good' cholesterol) shows a nuanced pattern: during perimenopause HDL may initially rise, but later it can decline or shift toward less protective subtypes (smaller HDL particles). Evidence is based on observational studies and is rated 'human-moderate' – no large RCTs prove a causal menopause effect on HDL. Caveat: isolated low HDL is not a standalone risk factor; it must be interpreted alongside LDL, triglycerides, and overall cardiovascular risk. Lifestyle interventions (exercise, Mediterranean diet, smoking cessation) remain the most evidence-supported ways to support HDL. Hormone therapy ma","sources":[],"title":"Evidence check: HDL in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-3fd14b1cbabd6d5fe86f0d7b/evidence-check-hdl-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The provided contexts contain no specific information on triglycerides in the context of menopause. Generally, it is known that the decline in estrogen during menopause shifts the lipid profile: LDL cholesterol and triglycerides often rise, while HDL cholesterol tends to decrease. This increases cardiovascular risk. Triglycerides are an important biomarker, modifiable by diet, exercise, and possibly hormone therapy. However, this statement is based on general medical knowledge, not on the given sources. Therefore, the evidence grade is 'unclear'. A triglyceride test during menopause can be useful but must be interpreted by a physician. Caveat: home tests provide only a snapshot and do not replace clinical diagnostics. If elevated, lifestyle changes and medical follow-up are recommended.","area":"gesundheit","canonical_id":"gesundheit:canonical-f9cd387fe16eeb879b152936","id":"public-16b49a797bc24bd8acab9e47","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Triglyceride in the context of menopause","score":20.34017456,"snippet":"The provided contexts contain no specific information on triglycerides in the context of menopause. Generally, it is known that the decline in estrogen during menopause shifts the lipid profile: LDL cholesterol and triglycerides often rise, while HDL cholesterol tends to decrease. This increases cardiovascular risk. Triglycerides are an important biomarker, modifiable by diet, exercise, and possibly hormone therapy. However, this statement is based on general medical knowledge, not on the given sources. Therefore, the evidence grade is 'unclear'. A triglyceride test during menopause can be useful but must be interpreted by a physician. Caveat: home tests provide only a snapshot and do not re","sources":[],"title":"Evidence check: Triglyceride in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-16b49a797bc24bd8acab9e47/evidence-check-triglyceride-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"During menopause, declining estrogen levels shift the lipid profile: LDL cholesterol typically rises, while HDL often remains stable or slightly decreases. This increase is a normal physiological change but elevates cardiovascular risk. Direct, evidence-based links between specific genetic variants (e.g., APOE, PCSK9) and LDL rise in menopause are weak. Most studies are observational with moderate effect sizes. Consumer tests like MyBody-X may offer SNP-based risk scores, but these are not sufficiently validated for predicting menopause-related LDL changes. Clinically, regular lipid monitoring, lifestyle modifications (diet, exercise), and possibly hormone therapy or statins are more relevant. The evidence for genetic testing in this context is 'human-moderate' to 'mixed'. Caveat: Elevated LDL in menopause warrants medical evaluation, not solely genetic interpretation.","area":"gesundheit","canonical_id":"gesundheit:canonical-bdb46bc43c80fbef6a135acd","id":"public-9700ed074a2a1b3a2a1371cf","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: LDL in the context of menopause","score":20.31525401,"snippet":"During menopause, declining estrogen levels shift the lipid profile: LDL cholesterol typically rises, while HDL often remains stable or slightly decreases. This increase is a normal physiological change but elevates cardiovascular risk. Direct, evidence-based links between specific genetic variants (e.g., APOE, PCSK9) and LDL rise in menopause are weak. Most studies are observational with moderate effect sizes. Consumer tests like MyBody-X may offer SNP-based risk scores, but these are not sufficiently validated for predicting menopause-related LDL changes. Clinically, regular lipid monitoring, lifestyle modifications (diet, exercise), and possibly hormone therapy or statins are more relevan","sources":[],"title":"Evidence check: LDL in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-9700ed074a2a1b3a2a1371cf/evidence-check-ldl-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The role of APOA2 in the context of menopause is not yet scientifically conclusive. APOA2 encodes apolipoprotein A-II, a component of HDL cholesterol. Some GWAS studies suggest that certain variants (e.g., rs5082) may influence weight regulation and lipid response to saturated fat. During menopause, estrogen decline alters lipid metabolism, increasing cardiovascular risk. Whether APOA2 modulates this effect is insufficiently supported. Effect sizes are small, and evidence comes mostly from association studies, not randomized controlled trials. Therefore, direct utility for personalized nutrition in menopause is questionable. Consumer DNA tests that include APOA2 often overstate clinical relevance. A healthy diet with moderate fat intake remains advisable regardless of genotype. Caveat: Results do not replace medical advice, especially in the presence of existing risk factors.","area":"gesundheit","canonical_id":"gesundheit:canonical-fb94c0d80b1326fa9e97bb4d","id":"public-19b3fc1899f27aaea3c378c9","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: APOA2 in the context of menopause","score":20.31126365,"snippet":"The role of APOA2 in the context of menopause is not yet scientifically conclusive. APOA2 encodes apolipoprotein A-II, a component of HDL cholesterol. Some GWAS studies suggest that certain variants (e.g., rs5082) may influence weight regulation and lipid response to saturated fat. During menopause, estrogen decline alters lipid metabolism, increasing cardiovascular risk. Whether APOA2 modulates this effect is insufficiently supported. Effect sizes are small, and evidence comes mostly from association studies, not randomized controlled trials. Therefore, direct utility for personalized nutrition in menopause is questionable. Consumer DNA tests that include APOA2 often overstate clinical rele","sources":[],"title":"Evidence check: APOA2 in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-19b3fc1899f27aaea3c378c9/evidence-check-apoa2-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The provided context documents contain no specific information linking the Cardio Risk Check (Herz-Kreislauf Risiko-Test) to menopause. It is well established that cardiovascular risk increases after menopause due to declining estrogen levels, affecting blood pressure, lipid profiles, and vascular function. A Cardio Risk Check, which typically includes biomarkers such as LDL, HDL, triglycerides, hsCRP, and possibly genetic risk variants (e.g., 9p21 locus), could therefore be particularly relevant for postmenopausal women. However, the available sources lack direct study data or product details to substantiate this connection. The evidence level is therefore classified as unclear. Consumers should be aware that such home tests are complementary, not a substitute, for medical screening. A physician consultation for risk stratification remains essential.","area":"gesundheit","canonical_id":"gesundheit:canonical-2fc426f52b8694ebd81f1ce1","id":"public-ad2118f692dfc9b3d17007e9","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"How are Cardio Risk Check | Herz-Kreislauf Risiko-Test and menopause related?","score":19.44799734,"snippet":"The provided context documents contain no specific information linking the Cardio Risk Check (Herz-Kreislauf Risiko-Test) to menopause. It is well established that cardiovascular risk increases after menopause due to declining estrogen levels, affecting blood pressure, lipid profiles, and vascular function. A Cardio Risk Check, which typically includes biomarkers such as LDL, HDL, triglycerides, hsCRP, and possibly genetic risk variants (e.g., 9p21 locus), could therefore be particularly relevant for postmenopausal women. However, the available sources lack direct study data or product details to substantiate this connection. The evidence level is therefore classified as unclear. Consumers s","sources":[],"title":"How are Cardio Risk Check | Herz-Kreislauf Risiko-Test and menopause related?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-ad2118f692dfc9b3d17007e9/how-are-cardio-risk-check-herz-kreislauf-risiko-test-and-menopause-related/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"ApoB (apolipoprotein B) is the primary structural protein of atherogenic lipoproteins (LDL, VLDL, IDL) and is considered a more accurate marker of cardiovascular risk than LDL cholesterol alone. During menopause, cardiovascular risk rises sharply due to estrogen decline – estrogen enhances LDL clearance and inhibits lipid oxidation. Studies indicate that postmenopausal women have higher ApoB levels compared to premenopausal women, independent of total cholesterol. Menopause also shifts LDL toward smaller, denser particles, which are more atherogenic and better captured by ApoB. However, the evidence base is not fully robust: no large randomized trials have specifically tested ApoB-lowering interventions in menopause. Most data come from observational studies and post-hoc analyses. Clinical guidelines (e.g., ESC/EAS) recommend ApoB as a secondary target, especially in women with metabolic syndrome or diabetes. In practice, measuring ApoB in menopausal women with elevated risk (e.g., early menopause, family history) can refine treatment decisions. Caveat: ApoB alone does not replace a full lipid panel (LDL, HDL, triglycerides) and should be interpreted alongside lifestyle, inflammatory markers (hsCRP), and hormonal status. Evidence is moderate – mechanistically sound but not confirmed by menopause-specific intervention trials.","area":"gesundheit","canonical_id":"gesundheit:canonical-56686c1136b2965adaf69603","id":"public-4fab64063a5c818ba35aab6f","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: ApoB in the context of menopause","score":19.40819997,"snippet":"ApoB (apolipoprotein B) is the primary structural protein of atherogenic lipoproteins (LDL, VLDL, IDL) and is considered a more accurate marker of cardiovascular risk than LDL cholesterol alone. During menopause, cardiovascular risk rises sharply due to estrogen decline – estrogen enhances LDL clearance and inhibits lipid oxidation. Studies indicate that postmenopausal women have higher ApoB levels compared to premenopausal women, independent of total cholesterol. Menopause also shifts LDL toward smaller, denser particles, which are more atherogenic and better captured by ApoB. However, the evidence base is not fully robust: no large randomized trials have specifically tested ApoB-lowering i","sources":[],"title":"Evidence check: ApoB in the context of menopause","url":"https://tikki.wiki/wissen/gesundheit/frage/public-4fab64063a5c818ba35aab6f/evidence-check-apob-in-the-context-of-menopause/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The Cardio Risk Check by MyBody-X can provide a rough orientation of cardiovascular risk during menopause, when declining estrogen levels increase heart disease risk. It measures markers like cholesterol (LDL/HDL), triglycerides, blood sugar, and inflammation. However, it is a lifestyle test, not a diagnostic tool. Values fluctuate and require medical interpretation. Do not adjust medication or lifestyle solely based on this test. Evidence: marketing/unclear. Sources: no specific studies in context; product description.","area":"gesundheit","canonical_id":"gesundheit:canonical-b9f3befe093edff5f40c1753","id":"public-6067e3dfbf6fca033668ddbc","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"What role does Cardio Risk Check play in Wechseljahre?","score":19.14380391,"snippet":"The Cardio Risk Check by MyBody-X can provide a rough orientation of cardiovascular risk during menopause, when declining estrogen levels increase heart disease risk. It measures markers like cholesterol (LDL/HDL), triglycerides, blood sugar, and inflammation. However, it is a lifestyle test, not a diagnostic tool. Values fluctuate and require medical interpretation. Do not adjust medication or lifestyle solely based on this test. Evidence: marketing/unclear. Sources: no specific studies in context; product description.","sources":[],"title":"What role does Cardio Risk Check play in Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-6067e3dfbf6fca033668ddbc/what-role-does-cardio-risk-check-play-in-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"The Cardio Risk Check measures standard lipid parameters (total cholesterol, LDL, HDL, triglycerides) and hsCRP as an inflammatory marker. During menopause, cardiovascular risk increases due to estrogen decline, which adversely affects lipid profiles and vascular function. The test can provide risk markers but cannot diagnose heart disease. Evidence is based on clinical practice, not randomized trials. A single test result is of limited value without considering age, blood pressure, smoking, diabetes, and family history. Moreover, this is a blood test, not a genetic test – it cannot identify inherited lipid disorders. For menopausal women, regular risk assessment is advisable, but the test should always be part of a comprehensive medical evaluation. Results can be influenced by acute inflammation, medications, or diet. Using a home test without medical guidance risks misinterpretation or false reassurance. Evidence grade: practice (established clinical markers).","area":"gesundheit","canonical_id":"gesundheit:canonical-b27edf85788d490ab9f8d37b","id":"public-3e042d07958d2bc8771c78d7","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Wechseljahre","score":18.97267958,"snippet":"The Cardio Risk Check measures standard lipid parameters (total cholesterol, LDL, HDL, triglycerides) and hsCRP as an inflammatory marker. During menopause, cardiovascular risk increases due to estrogen decline, which adversely affects lipid profiles and vascular function. The test can provide risk markers but cannot diagnose heart disease. Evidence is based on clinical practice, not randomized trials. A single test result is of limited value without considering age, blood pressure, smoking, diabetes, and family history. Moreover, this is a blood test, not a genetic test – it cannot identify inherited lipid disorders. For menopausal women, regular risk assessment is advisable, but the test s","sources":[],"title":"Evidence check: Cardio Risk Check | Herz-Kreislauf Risiko-Test in the context of Wechseljahre","url":"https://tikki.wiki/wissen/gesundheit/frage/public-3e042d07958d2bc8771c78d7/evidence-check-cardio-risk-check-herz-kreislauf-risiko-test-in-the-context-of-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}},{"answer":"Whether a Cardio Risk Check is useful during menopause (Wechseljahre) depends on the specific markers included and the individual's baseline risk. Menopause is associated with a decline in estrogen, which increases cardiovascular risk—affecting lipid profiles, blood pressure, and vascular function. A comprehensive check that includes standard lipids (LDL, HDL, triglycerides), blood pressure, fasting glucose, and possibly hs-CRP can provide valuable insight. However, the evidence for routine screening in perimenopausal women is moderate; many guidelines recommend risk assessment starting at age 40–45. Consumer tests may include additional markers (e.g., Lp(a), ApoB) that have emerging evidence but are not yet universally recommended. The utility is highest when results are interpreted by a clinician and combined with lifestyle factors. Caveat: a single test does not diagnose disease, and over-testing can lead to unnecessary anxiety. Evidence level: practice (established medical practice) with moderate support from guidelines. Sources: none from provided context; general medical consensus.","area":"gesundheit","canonical_id":"gesundheit:canonical-3049975753fbff794ddd57e3","id":"public-0d36aa4284a9d0da95835378","kind":"qa","language":"en","publication_status":"existing_native_answer_privacy_screened_sources_pending","question":"Is Cardio Risk Check useful for Wechseljahre?","score":18.59361597,"snippet":"Whether a Cardio Risk Check is useful during menopause (Wechseljahre) depends on the specific markers included and the individual's baseline risk. Menopause is associated with a decline in estrogen, which increases cardiovascular risk—affecting lipid profiles, blood pressure, and vascular function. A comprehensive check that includes standard lipids (LDL, HDL, triglycerides), blood pressure, fasting glucose, and possibly hs-CRP can provide valuable insight. However, the evidence for routine screening in perimenopausal women is moderate; many guidelines recommend risk assessment starting at age 40–45. Consumer tests may include additional markers (e.g., Lp(a), ApoB) that have emerging evidenc","sources":[],"title":"Is Cardio Risk Check useful for Wechseljahre?","url":"https://tikki.wiki/wissen/gesundheit/frage/public-0d36aa4284a9d0da95835378/is-cardio-risk-check-useful-for-wechseljahre/","verification":{"claim_support_verified":false,"human_reviewed":false,"quote_exact_match":false,"source_identity_verified":false,"tier":"existing_native_answer_privacy_screened_sources_pending"}}],"schema_version":"tikki.search-response.v1"}